3MINDIA - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.1
| Stock Code | 3MINDIA | Market Cap | 37,403 Cr. | Current Price | 33,233 ₹ | High / Low | 38,300 ₹ |
| Stock P/E | 69.0 | Book Value | 1,430 ₹ | Dividend Yield | 0.48 % | ROCE | 49.9 % |
| ROE | 29.4 % | Face Value | 10.0 ₹ | DMA 50 | 32,413 ₹ | DMA 200 | 32,663 ₹ |
| Chg in FII Hold | 0.02 % | Chg in DII Hold | -0.05 % | PAT Qtr | 185 Cr. | PAT Prev Qtr | -113 Cr. |
| RSI | 60.1 | MACD | -55.2 | Volume | 50,567 | Avg Vol 1Wk | 14,277 |
| Low price | 27,830 ₹ | High price | 38,300 ₹ | PEG Ratio | 7.46 | Debt to equity | 0.06 |
| 52w Index | 51.6 % | Qtr Profit Var | 160 % | EPS | 464 ₹ | Industry PE | 19.8 |
📊 Financials: 3M India demonstrates strong fundamentals with ROE at 29.4% and ROCE at 49.9%, indicating efficient capital utilization. Debt-to-equity is very low at 0.06, reflecting a conservative balance sheet. Quarterly PAT rebounded to ₹185 Cr. from a loss of ₹113 Cr., showing a 160% profit variance. EPS is robust at ₹464, highlighting strong earnings power.
💰 Valuation: The stock trades at a P/E of 69, significantly higher than the industry average of 19.8, suggesting overvaluation. P/B ratio is ~23.2 (Price ₹33,233 / Book Value ₹1,430). PEG ratio of 7.46 indicates expensive growth expectations. Intrinsic value appears lower than current price, making entry less attractive at present levels.
🏢 Business Model: 3M India operates across diversified industrial, healthcare, and consumer segments, leveraging global brand strength and innovation. Its competitive advantage lies in product diversity, R&D capabilities, and strong market positioning. Overall health is solid, supported by high returns and low leverage.
📈 Entry Zone: A more attractive entry would be closer to ₹28,000–30,000, near its 52-week low. Current valuation is stretched. Long-term holding is justified given strong fundamentals, but investors should wait for better valuation levels before fresh entry.
Positive
- 📌 Strong ROE (29.4%) and ROCE (49.9%)
- 📌 Very low debt-to-equity ratio (0.06)
- 📌 EPS of ₹464 reflects strong earnings
- 📌 PAT rebound from loss to ₹185 Cr.
Limitation
- ⚠️ High P/E ratio (69) vs industry average (19.8)
- ⚠️ Expensive P/B ratio (~23.2)
- ⚠️ PEG ratio of 7.46 signals costly growth
- ⚠️ Dividend yield of 0.48% is modest
Company Negative News
- 📉 Slight decline in DII holdings (-0.05%)
Company Positive News
- 📈 Marginal increase in FII holdings (+0.02%)
- 📈 Strong quarterly profit recovery
Industry
- 🏦 Industry PE at 19.8, far below 3M India’s valuation
- 📊 Industrial and healthcare sectors benefit from rising demand in India
Conclusion
🔎 3M India is a fundamentally strong company with excellent return ratios and low debt. However, current valuations are stretched. Entry is advisable near ₹28,000–30,000. Long-term holding is favorable given the company’s diversified business model and strong fundamentals, but investors should be cautious about valuation risks.
Would you like me to also prepare a valuation comparison chart between 3M India and industry peers to visualize the premium it trades at?